Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.39 USD | +0.48% | +2.87% | +69.22% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.62M | Sales 2025 * | 4.94M | Capitalization | 393M |
---|---|---|---|---|---|
Net income 2024 * | -95M | Net income 2025 * | -120M | EV / Sales 2024 * | 67.2 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 65.9 x |
P/E ratio 2024 * |
-3.83
x | P/E ratio 2025 * |
-3.76
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.91% |
Latest transcript on Solid Biosciences Inc.
1 day | +0.48% | ||
1 week | +2.87% | ||
Current month | +17.14% | ||
1 month | +0.19% | ||
3 months | +28.75% | ||
6 months | +370.14% | ||
Current year | +69.22% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 10.39 | +0.48% | 175,420 |
24-05-09 | 10.34 | +0.88% | 67,663 |
24-05-08 | 10.25 | -1.63% | 106,454 |
24-05-07 | 10.42 | +4.20% | 174,822 |
24-05-06 | 10 | -0.99% | 173,603 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.22% | 393M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SLDB Stock